3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
60
Lymphoma
56
Leukemia, Myeloid, Acute
51
Leukemia
50
Lymphoma, Non-Hodgkin
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Hodgkin Disease
36
Myelodysplastic Syndromes
28
Lymphoma, Large B-Cell, Diffuse
27
Breast Neoplasms
24
Lymphoma, Mantle-Cell
23
Neuroblastoma
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Burkitt Lymphoma
17
Lymphoma, Follicular
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Central Nervous System Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Sarcoma
11
Neoplasms, Plasma Cell
11
Brain Neoplasms
11
Recurrence
10
Lymphoma, B-Cell, Marginal Zone
10
Neoplasms
9
Hematologic Neoplasms
9
Congenital Abnormalities
9
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Biphenotypic, Acute
8
Graft vs Host Disease
8
Interventions
Lenalidomide
4
Bortezomib
4
Dexamethasone
3
vandetanib
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
2
liposomal doxorubicin
2
Doxorubicin
2
tremelimumab
1
tivozanib
1
ricolinostat
1
pomalidomide
1
pazopanib
1
nilotinib
1
durvalumab
1
avelumab
1
abexinostat
1
Transplantation, Autologous
1
Tamoxifen
1
Steroids
1
Standard of Care
1
Practice Guidelines as Topic
1
Parenteral Nutrition
1
Palliative Care
1
Paclitaxel
1
Nivolumab
1
NVP-BKM120
1
Melphalan
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Disease Progression
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts